Skip to: Content
Skip to: Site Navigation
Skip to: Search
TUESDAY, FEBRUARY 9, 2010
 |  Follow Newser on Twitter   Friend Newser on Facebook   Subscribe to Newser's RSS feeds   Subscribe to Newser emails Newsletters


0

Prices Jump for Top Drugs

Drug giants collect now against expected future losses

Share

(Newser) – Drug companies have slapped a series of huge price hikes on some prescription drugs ahead of drug patent expirations, the Wall Street Journal reports. GlaxoSmithKline has raised the price of antidepressant Wellbutrin 44.5%, while Sanofi-Aventis hiked Ambien's price 70%. Wholesale prices for the top 50 drugs increased an average of nearly 8% last year.

Some price hikes are designed to nudge consumers off now-more-expensive brands whose patents are about to expire to reformulated brands with longer patent protection. The increases are driving up co-pays and health insurance costs. With few new drugs in the pipeline, maximizing profit on existing drugs has become essential. All the leading presidential candidates have been critical of the pharmaceutical giants and their prices.

Major drug companies have imposed huge price hikes on some of their leading drugs, maximizing profits before their patents expire. (AP Photo/Mark Lennihan, File)
Major drug companies have imposed huge price hikes on some of their leading drugs, maximizing profits before their patents expire. (AP Photo/Mark Lennihan, File)   (Associated Press)
A selection of prescription drugs, including Allegra, Zyprexa, Levitra, Cialis and Lipitor (AP Photo/Michael Conroy)
A selection of prescription drugs, including Allegra, Zyprexa, Levitra, Cialis and Lipitor (AP Photo/Michael Conroy)   (Associated Press)
Some drug companies have slapped double digit price increases on their best selling prescription drugs. (AP Photo/Mel Evans, File)
Some drug companies have slapped double digit price increases on their best selling prescription drugs. (AP Photo/Mel Evans, File)   (Associated Press)
Drug giants like GlaxoSmithKline face huge losses as the patents on leading drugs expire. Some companies have increased their prices by over 70%.(AP Photo/Brennan Linsley, file)
Drug giants like GlaxoSmithKline face huge losses as the patents on leading drugs expire. Some companies have increased their prices by over 70%.(AP Photo/Brennan Linsley, file)   (Associated Press)
« Prev« Prev | Next »Next » Slideshow
OFF THE GRID
2.9.10
It’s the Sex, Stupid   
2.8.10
For Me, Palin Scores
0 comments
VIEWING:
 
LEAVE A
COMMENT Comment Policy
Facebook ConnectPost this comment to Facebook?

After connecting you will have the option to post your comment on your Facebook profile.

 

Related Newser Stories

1 Story

OPINION

Blogger Weighs Health Care Plans, Flunks McCain

Clinton edges Obama in real-life take on insurance reform

Apr 25, 08 4:40 PM CDT

Blogger Weighs Health Care Plans, Flunks McCain

Clinton edges Obama in real-life take on insurance reform

(Newser) - Hacking through the forest of reporting on the presidential candidates' health care plans, Glamour blogger Megan Carpentier weighs in. Writing "as someone born with a birth defect who has been known to get sick," she bluntly begins, "I know enough about my own health insurance situation over... More »

1 Story


Drug Prices

FDA panel back Glaxo's Rotarix
Wall Street Journal

Pfizer has its heart on its sleeve
Forbes

 
Barack Obama • Hillary Clinton • John McCain • antidepressant • drug companies • GlaxoSmithKline • Pfizer • health insurance premiums • price increases • health care reform • Centers for Medicare and Medicaid Services • Lipitor • pharmaceutical industry • co-pays • Ambien • Wellbutrin • Adderall XR • Sanofi-Aventis • Shire • patent expiration

from our news partners

Please wait, content is loading
Please wait, content is loading

Just For Laughs

Loading...